2023 end-of-year portfolio review

My most popular post of the year is invariably the annual performance review. It is pointless to compare yourself to a random person on the internet, but I get it, curiosity also gets the best of me when someone else is sharing results. In 2023 the portfolio produced a return of 10.47% which in absolute sense is pretty good, but at the same time it is setting some negative records.  It’s a bit of a first-world problem when you can bitch about a double digit positive return, but besides being the lowest absolute return so far it is sadly also breaking my streak of beating the MSCI All County World Index every single year in a row. The key distinction between me and the index lies in my positive return the previous year, and if you don’t need to recover from a loss you start with a big head start. Taking 2022 as starting point the MSCI ACWI is up a meager 3.7% while my portfolio produced a 23.3% return. Like I said, first-world problems…

Year Return* Benchmark** Difference
2012 18.44% 15.01% 3.43%
2013 53.38% 18.11% 35.26%
2014 30.11% 19.23% 10.88%
2015 24.23% 9.34% 14.89%
2016 64.97% 11.73% 53.24%
2017 29.04% 9.47% 19.57%
2018 13.07% -4.34% 17.41%
2019 32.34% 28.93% 2.70%
2020 19.31% 7.18% 12.13%
2021 31.31% 28.08% 3.23%
2022 11.63% -12.58% 24.21%
2023 10.47% 18.65% -8.18%
Cumulative 1706.73% 282.47% 1424.26%
CAGR 27.27% 11.83% 15.45%

* Return in euro’s after transaction costs, net dividend withholding taxes and other expenses
** Benchmark is the MSCI ACWI (All Country World Index) gross total return index in euro’s

Long-time followers of the blog will see a familiar picture in the performance attribution graph below, with the special situations bucket being the driving force behind the portfolio. But I will admit that sometimes the lines are a bit blurry between which stock goes where. The number two position in the list is Garrett Motion, that I bought as a special situation when it entered bankruptcy proceedings, but was promoted to a long-term value pick after a successful restructuring. On the other hand, one of the major contributors in the special situation bucket is a stock that was spun-off after a successfully completed merger arbitrage, and it would certainly make sense to reclassify it to a long-term position. And sometimes the line is already blurry from the start. I think most investors would see investing in spin-offs as special situation investing, but how long can you hold it and still see it that way?

Also noteworthy is that during the year a meaningful contribution was made by interest income. Not only because interest rates went up a lot and you finally get paid something on your idle cash balance, but also because my cash balance was unusually high. We are looking to buy a house, and while that search is ongoing I want to keep my options open. That presumably incurred a significant opportunity cost, but investment results aren’t always the most important in life. Or maybe never? With that philosophical question I want to conclude this post, and wish my readers a happy, healthy and prosperous 2024.

Disclosure

Author is long most of the stuff mentioned in the performance attribution graph

Always worry about your edge

I was reading “Stop worrying about your edge” on the excellent Turtles all the way down! blog, and couldn’t resist writing the oppositely titled post. Not because I disagree with the post. Maybe on some details, but I think he makes some good points. But the truth is that every intelligent sounding investment quote breaks down at some level. People for example love to quote Buffett – and you could certainly catch me doing it from time to time – but it is important to realize that nothing is universally true. Or some types of advice sound good, but simply don’t work in real-life.

Consider the famous poker quote, “If you can’t spot the sucker in your first half hour at the table, then you are the sucker.” Hard to disagree with, right? But the thing is, that usually, the sucker is also convinced that he has spotted some players that he can beat. Perhaps he has seen some excellent pro’s involved in a big bluf, and thinks that they are spewing money away. He is wrong of course, but without the knowledge to recognize what is going on, he doesn’t have the tools to evaluate his own position at the table. And it is not like you need to be a total fool to not recognize your own place at the table. Many mediocre poker professionals – that objectively are miles ahead of the total amateur – can’t recognize better playing professionals. Their perspective is limited to what they know, and from their vantage point, the better players seem to be making errors. So, in reality, usually only the best poker players at the table can accurately estimate the skill level of everyone else. However, merely advising people to be one of the best players at the table is not a practical tip.

But to circle back to worrying about having an edge in investing. I agree that it is incredible hard to know if you have an edge in a specific investment or in investing in general. And because it is hard to know, you should always be worried that you don’t have an edge. I think this idea should be constantly on the back of your mind, shaping your investment strategy. Everything you do should be with the assumption that you could have no edge.

So, how can you invest while holding that belief? I personally think that the following three guidelines can keep you out of trouble.

  1. Diversify: Never bet big on a single name. If you invest in a sufficiently big basket of random names your expected return should be close to the expected return of the market. If you lack an edge, this approach minimizes potential harm from an expected value perspective.
  2. Minimize costs: When your investments have a neutral expected value compared to the market, the main source of underperformance comes from frictional costs associated with your strategy. Therefore, make sure you avoid incurring excessive trading fees or unnecessarily high taxes.
  3. Stay away from risky corners: Acquiring an edge is difficult, but losing money is easy. Avoid stocks with high short interest and/or no borrow, as they are almost certain to decline. Also, be cautious with recent IPOs, SPACs, or any other investment fads.

There will be times to break the guidelines above, but I think this should be a healthy starting point for most investors. I will not claim this would have saved every investor who blew up in recent times, but it would probably have come close. The downside is, of course, that you are also not getting lucky by betting it all on one stock and making it big. To actually make money like this, you absolutely need a  consistent edge. Bet after bet. Stock after stock. You will not know in advance if you have an edge, but after enough years, you should get an idea.

So you heard it. Stop worrying about your edge, but also, always worry about your edge!

ALJ Regional Holdings merger completed

A bit less than two months ago I wrote about the ALJ Regional Holdings going private transaction. The merger closed at the end of last month, but because of some confusing language in the merger documents people where not totally sure if accredited investors would get cash, or would be forced to accept the stock option. I thought it would basically impossible for the company to take this route, because issuing unregistered shares to non-accredited investors could get them in a lot of trouble. Today my broker put the corporate action in their system, and that makes it crystal clear that, if you do nothing, you indeed get the cash option:

Holders electing for the Stock election, Option 2, must complete the Verification Request Form and send back to IBKR for submission to the agent. Once the Verification Request Form has been received by the Information Agent, New ALJ will instruct a third-party accredited investor verification service, VerifyInvestor.com, to initiate the verification process. Holders will receive an electronic communication from the Verification Provider at the email address provided on the Verification Request Form containing instructions to follow in order to complete the verification process. In addition, the Verification Provider or New ALJ’s other representatives or agents may further reach out to confirm whether such investor would qualify as a sophisticated investor in New ALJ’s sole discretion.

Once the verification process is complete, and you receive the confirmation to move forward with the stock election, IBKR will be able to submit the tender electronically via DTC. IBKR cannot tender the shares without receiving the approval from the verification process.

It will probably take till the end of this month for the merger payout to hit my account, but I think we can safely call this trade a success.

Disclosure

Author has no idea if he is still long or not. The shares are still visible in my account, but since the merger closed I guess I technically don’t own them anymore?

Switch from Feedburner to follow.it

At the end of 2021 Google decided to put Feedburner in maintenance mode which caused the email subscription feature to stop working. After getting some comments from readers I decided to fix this issue, and after a quick look on Google I ended up at follow.it as Feedburner replacement. All existing e-mail subscribers have been migrated to follow.it, and should once again receive e-mail updates when new content is posted. Besides offering a RSS-feed with e-mail subscriptions there are now some additional features available as well such as the option to use filters or a Chrome extension for notifications. Let me know in the comments if everything is now working again as expected.

PDL Biopharma liquidation making progress

At the end of 2020 I wrote enthusiastically about the PDL Biopharma liquidation. At the time the stock was trading at $2.35/share while I estimated approximately $3.35 in liquidation distributions. Last Friday the company paid a third distribution to shareholders, bringing the total amount distributed to shareholders to $2.05/share. While I’m close to recovering my initial investment, I think it’s clear that my 27% IRR estimate was way too optimistic. Based on the third quarter ’22 update remaining net assets are approximately $1.61/share. Even if the remainder of the liquidation is now quickly concluded, and we get that amount in one year time, the IRR is “just” 19%. If we have to wait another full 3 years, which might be more realistic, the IRR drops to 14.5%. While PDL Biopharma seems to follow the golden rule that liquidations always take more time than you expect, I think the end result will be nonetheless quite satisfactory.

Balance sheet before taking 2nd ($24.1 million) and 3rd ($95.9 million) liquidation distributions into account

Disclosure

Author is long PDL Biopharma